Is no one else concerned about the diverging opinions mentioned at the end of the quarterly activities report?
We're all hoping for a smidgen of good news on the Ablation front and all we get is the same "in discussions" line and a casual mention on diverging opinions on how to proceed with commercialisation. This line here is more worrying to me than any take-over offer!